Cardio Diagnostics Hldgs Inc (CDIO) Stock Price, Quote & News

Company Profile

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights...

Industry: Biotechnology

Sector: Healthcare

Phone: 855 226 9991

Website: cdio.ai

Address:

311 West Superior Street, Suite 444, Chicago, United States

ModernControl Mar. 21 at 6:22 PM

$CDIO is on radar, just watching.

0 · Reply

oldtradeboy135 Mar. 21 at 12:04 AM

$CDIO CDIO just filed their Annual Report (10-K) on March 13, 2026, which contains a "smoking gun" for the shorts: Cash Position: Despite being a small company, they have a Current Ratio of 17.4. This means they are not going bankrupt anytime soon—destroying the main thesis of the short sellers. The $854 "Check": The 10-K re-confirmed the $854 CMS rate for both main tests. The Share Count: After the 1-for-30 reverse split, there are only ~2.95M shares outstanding. With such a tiny float, if the "Sell the News" crowd from February tries to cover their 50% short volume on Monday, the price can move $1.00+ on very low volume.

0 · Reply

oldtradeboy135 Mar. 20 at 11:59 PM

$CDIO Borrow Fee: 233.68% — This is an extreme level. Short sellers are paying an annual rate of over 200% just to keep their bets open. Every day they stay in the trade, they are losing significant money to interest. Short Shares Availability: Very Low — Availability has been hitting 0 shares frequently in the last few days. When "inventory" is zero, any buyer who steps in has total control because the shorts cannot "refill" their positions to push the price back down. Short Volume Ratio: 50.04% — On Friday, half of all trades were shorts. If the price starts to move up, half of the people in the stock will be in a panic to exit at the same time.

0 · Reply

oldtradeboy135 Mar. 20 at 11:56 PM

$CDIO Q2 starts in just a couple of weeks (April 1st). The market knows that the moment CDIO announces they are actively cashing those $854 checks from insurers, the stock will re-value immediately.

0 · Reply

oldtradeboy135 Mar. 20 at 11:56 PM

$CDIO This rate officially went into effect on January 1, 2026. Think about this from the perspective of a bear paying a 233% borrow fee: They shorted CDIO thinking it was just a tiny, cash-burning biotech company with a "science project." Suddenly, CDIO has an official, government-backed $854 reimbursement rate for tests that cost them almost nothing to run (which is why they boast near 100% gross margins). If CDIO scales this up and runs just 10,000 tests, that's over $8.5 Million in pure revenue for a company whose entire market cap is currently only around $6.8 Million. The math is terrifying for a short seller.

0 · Reply

oldtradeboy135 Mar. 20 at 11:54 PM

$CDIO Precedent M&A: In the last year, several AI-cardiology firms have been acquired. Analysts have noted that CDIO’s "proven IP" and "strategic positioning" make it a logical buyout candidate in the $8.00 – $21.00 price range.

0 · Reply

oldtradeboy135 Mar. 20 at 11:54 PM

$CDIO

0 · Reply

oldtradeboy135 Mar. 20 at 11:49 PM

$CDIO The Trap: You might see a huge sell order (e.g., 50,000 shares) appear at $2.75 just to scare retail into selling.

0 · Reply

KimberleyAnn Mar. 20 at 5:39 PM

$CDIO $AZTR $FCHL

1 · Reply

Redsox1975 Mar. 20 at 4:38 PM

$CDIO timberrrrrrrrr

0 · Reply

CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. to Host Investor Call on Thursday, February 19, 2026

Feb 17, 2026, 8:35 AM EST - 4 weeks ago

Cardio Diagnostics Holdings, Inc. to Host Investor Call on Wednesday, February 18, 2026

Jan 7, 2026, 6:25 AM EST - 2 months ago

Cardio Diagnostics, Aimil Ltd. and Dr. Lal PathLabs Limited Partner to Launch the PrecisionCHD™ Test in India

Jan 6, 2026, 8:35 AM EST - 2 months ago

Cardio Diagnostics Holdings, Inc. and Southdale YMCA Announce New Heart Health Partnership to Serve the Edina, Minnesota Community

Dec 3, 2025, 8:35 AM EST - 3 months ago

Cardio Diagnostics Receives Final Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)

Nov 5, 2025, 8:35 AM EST - 4 months ago

Cardio Diagnostics Holdings, Inc. to Present Data Demonstrating PrecisionCHD's Ability to Detect INOCA and MINOCA at the American Heart Association Scientific Sessions

Oct 28, 2025, 8:35 AM EDT - 5 months ago

Cardio Diagnostics Holdings, Inc. and YMCA of East Tennessee Partner to Bring Heart Health Education and Advanced Testing to East Tennessee Community

Oct 21, 2025, 8:35 AM EDT - 5 months ago

Cardio Diagnostics Holdings, Inc. Expands Provider Network, Adding 15 New Provider Organizations From Across the United States

Jul 22, 2025, 8:31 AM EDT - 8 months ago

Cardio Diagnostics Receives Gapfill Payment Rates for AI-Driven Cardiovascular Tests from the Centers for Medicare and Medicaid Services (CMS)

Jul 8, 2025, 8:31 AM EDT - 9 months ago

Cardio Diagnostics Enters Into an Agreement with AGEPHA Pharma to Advance Precision Assessment and Management of Inflammation Associated with Coronary Heart Disease

Jun 10, 2025, 8:35 AM EDT - 10 months ago

Cardio Diagnostics Secures Japanese Patent for AI-Driven Cardiovascular Disease Detection Technology

May 29, 2025, 8:35 AM EDT - 10 months ago

Cardio Diagnostics Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price

May 20, 2025, 8:35 AM EDT - 10 months ago

Cardio Diagnostics Broadens Access to Precision Cardiovascular Care with New Practice Partnerships Across U.S. Mainland and Puerto Rico

May 8, 2025, 8:35 AM EDT - 11 months ago

Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split

Mar 26, 2025, 8:31 AM EDT - 1 year ago

Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology's 74th Annual Scientific Session

Feb 4, 2025, 8:31 AM EST - 1 year ago

Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations

Dec 16, 2024, 8:31 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

Nov 12, 2024, 8:31 AM EST - 1 year ago

Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference

Oct 1, 2024, 8:31 AM EDT - 1 year ago

Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

Jul 29, 2024, 8:45 AM EDT - 1 year ago

Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions

Jun 27, 2024, 8:31 AM EDT - 1 year ago

Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

Jun 25, 2024, 8:31 AM EDT - 1 year ago

Cardio Diagnostics Announces It's Exhibiting at the 2024 Onsite Employee Health Clinics Forum

Jun 10, 2024, 8:31 AM EDT - 1 year ago

Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality

May 21, 2024, 8:31 AM EDT - 1 year ago

Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services' (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests

May 13, 2024, 8:31 AM EDT - 2 years ago

Cardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists' Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a Week

Apr 29, 2024, 8:31 AM EDT - 2 years ago

Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million Annually

Apr 9, 2024, 8:31 AM EDT - 2 years ago

Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in Michigan

Apr 4, 2024, 8:31 AM EDT - 2 years ago

Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre

Mar 14, 2024, 8:31 AM EDT - 2 years ago

Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology's 73rd Annual Scientific Session

Mar 5, 2024, 8:31 AM EST - 2 years ago

Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease

Feb 15, 2024, 8:46 AM EST - 2 years ago

Cardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide Rollout

Feb 7, 2024, 8:31 AM EST - 2 years ago

Cardio Diagnostics Holdings, Inc. Expands Partnership with Family Medicine Specialists to Bring Its Specialty Cardiology Tests to Select Walmart Supercenters

Feb 5, 2024, 8:31 AM EST - 2 years ago

Houston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics' AI-Driven Epigenetic-Genetic Heart Disease Tests

Jan 24, 2024, 8:31 AM EST - 2 years ago

Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor

Jan 8, 2024, 8:31 AM EST - 2 years ago

Cardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in India

Jan 4, 2024, 11:36 AM EST - 2 years ago

CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™

Jan 4, 2024, 8:31 AM EST - 2 years ago

Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™

Jan 3, 2024, 8:31 AM EST - 2 years ago

American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event

Jan 2, 2024, 8:31 AM EST - 2 years ago

American Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.'s AI-Powered Coronary Heart Disease Detection Test, PrecisionCHD, a Dedicated CPT PLA Reimbursement Code

Dec 21, 2023, 9:21 AM EST - 2 years ago

Cardio Diagnostics Holdings, Inc. Appoints Biotechnology Investor, Executive & Serial Entrepreneur Paul Burton to its Board of Directors

Dec 6, 2023, 8:31 AM EST - 2 years ago

Cardio Diagnostics Holdings, Inc. Regains Nasdaq Minimum Bid Price Requirement

Dec 4, 2023, 5:38 PM EST - 2 years ago

CORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Convenes Cardiovascular Care & Risk Roundtable at the 42nd Annual J.P. Morgan Healthcare Conference

Dec 4, 2023, 8:31 AM EST - 2 years ago

Cardio Diagnostics Holdings, Inc's Convenes Cardiovascular Care & Risk Roundtable at the 42nd Annual J.P. Morgan Healthcare Conference

Nov 28, 2023, 8:31 AM EST - 2 years ago

American Medical Association is Reviewing Cardio Diagnostics Holdings, Inc's Integrated Epigenetic-Genetic Cardiovascular Medicine Tests for CPT PLA Codes

Nov 20, 2023, 8:31 AM EST - 2 years ago

Cardio Diagnostics Holdings, Inc. Announces Breakthrough in Coronary Heart Disease Detection with PrecisionCHD Test, Published in the Journal of the American Heart Association

Nov 7, 2023, 9:01 AM EST - 2 years ago

Family Medicine Specialists Selects Cardio Diagnostics' Epigenetic-Genetic Tests for Assessing Heart Attack Risk for its BlueCross BlueShield Patients

Oct 31, 2023, 9:01 AM EDT - 2 years ago

Cardio Diagnostics Holdings, Inc Receives Innovative Technology Contract from Vizient for Its Novel AI-Driven Precision Heart Disease Tests – Epi+Gen CHD & PrecisionCHD

Oct 17, 2023, 9:01 AM EDT - 2 years ago

Cardio Diagnostics Holdings, Inc and Aimil Ltd Join Forces to Introduce Cardiovascular Epigenetic Technologies to India

Oct 12, 2023, 8:30 AM EDT - 2 years ago

Cardio Diagnostics Holdings, Inc Launches New Lab and Fulfillment Center, Paving Way for Expanded Testing Capacity, Reduced Costs, Reduced Turnaround Time and Improved Margins

Sep 20, 2023, 9:01 AM EDT - 2 years ago

Cardio Diagnostics Publishes Novel and Scalable Pathways to Enhance Global Coronary Heart Disease Care through Precision Epigenetics in Epigenomics

ModernControl Mar. 21 at 6:22 PM

$CDIO is on radar, just watching.

0 · Reply

oldtradeboy135 Mar. 21 at 12:04 AM

0 · Reply

oldtradeboy135 Mar. 20 at 11:59 PM

0 · Reply

oldtradeboy135 Mar. 20 at 11:56 PM

$CDIO Q2 starts in just a couple of weeks (April 1st). The market knows that the moment CDIO announces they are actively cashing those $854 checks from insurers, the stock will re-value immediately.

0 · Reply

oldtradeboy135 Mar. 20 at 11:56 PM

0 · Reply

oldtradeboy135 Mar. 20 at 11:54 PM

0 · Reply

oldtradeboy135 Mar. 20 at 11:54 PM

$CDIO

0 · Reply

oldtradeboy135 Mar. 20 at 11:49 PM

$CDIO The Trap: You might see a huge sell order (e.g., 50,000 shares) appear at $2.75 just to scare retail into selling.

0 · Reply

KimberleyAnn Mar. 20 at 5:39 PM

$CDIO $AZTR $FCHL

1 · Reply

Redsox1975 Mar. 20 at 4:38 PM

$CDIO timberrrrrrrrr

0 · Reply

Noveto Mar. 20 at 4:24 PM

$CDIO market is red today. Shorts in are in full force.

2 · Reply

Noveto Mar. 20 at 4:23 PM

$CDIO it just needs time. You can buy a cheap whiskey or wine and everyone can have it. But the better ones come with time. This just needs time. Shorts will make their money of the fools they fear losing. Holding strong.

0 · Reply

Redsox1975 Mar. 20 at 3:54 PM

$CDIO 1.9 bil people between india an USA and this scam has sold zero tests tells you something about this scam

0 · Reply

oldtradeboy135 Mar. 20 at 1:49 PM

$CDIO $GME $TSLA $NVDA

0 · Reply

oldtradeboy135 Mar. 20 at 1:23 PM

$CDIO My focus: what’s gonna happen, and at what price we traders finally say, “Alright Mr. Chairman warren … you can have the company” — but only after we sell it to you for way more than it’s worth 20+ 😏📈💰

0 · Reply

resurrect_momo21 Mar. 19 at 6:09 PM

$CDIO 20 cent squeeze spread

0 · Reply

Coupedayville Mar. 19 at 5:22 PM

$CDIO So they obviously diluted based on market cap and haven’t filed notice yet with SEC. I’m amazed it’s up at 2.50 range after that Report and dilution! This is how they ended up a .16 cents pre Reverse split in 2024. It’s an equivalent of .08 cents now and they diluted! This is nothing but a scam to suck investors dry! Over 100M in losses and can’t do but $1100 a month avg in sales! That’s what 2-3 test! Geezus

1 · Reply

I_H8_SHORTS Mar. 19 at 4:57 PM

$CDIO AMAZON!!! is a great company to order from online!

0 · Reply

Opsectrade Mar. 19 at 4:55 PM

$CDIO 🫨😊

0 · Reply

DirtyErnie Mar. 19 at 3:41 PM

$CDIO back in at 2.41

0 · Reply

topstockalerts Mar. 19 at 3:41 PM

$CDIO choppy but has shown it can spike. Not clean, more of a trade-the-move type ticker.

0 · Reply

resurrect_momo21 Mar. 19 at 3:29 PM

$CDIO lockled in with good size now for the new MOMO squeeze going to fun

1 · Reply

Market Cap	4.24M
Revenue (ttm)	20,000.00
Net Income (ttm)	-6.50M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-32,500.00%
Debt to Equity Ratio	0.00

Volume	375,100
Avg Vol	4,526,762
Day's Range	N/A - N/A
Shares Out	1.83M
Stochastic %K	4%
Beta	2.28
Analysts	Sell
Price Target	$8.00